| Bioactivity | SARS-CoV-2-IN-12 (Compound 27) is a potent SARS-CoV-2-related 3C-like protease inhibitor (Ki=32.1 pM) for preventing SARS-CoV-2 viral replication and that could be useful in the research of COVID-19[1]. |
| Name | SARS-CoV-2-IN-12 |
| CAS | 2721455-52-1 |
| Formula | C32H42F3N5O9 |
| Molar Mass | 697.70 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ram W Sabnis. Novel Compounds for Preventing SARS-CoV-2 Viral Replication and Treating COVID-19. ACS Med Chem Lett. 2021 Nov 18;12(12):1887-1888. |
SARS-CoV-2-IN-12
CAS: 2721455-52-1 F: C32H42F3N5O9 W: 697.70
SARS-CoV-2-IN-12 (Compound 27) is a potent SARS-CoV-2-related 3C-like protease inhibitor (Ki=32.1 pM) for preventing SAR
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.